Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-19,700
Closed -$3.81M 184
2019
Q3
$3.81M Buy
19,700
+7,600
+63% +$1.46M 0.47% 45
2019
Q2
$2.23M Sell
12,100
-16,100
-57% -$2.88M 0.16% 112
2019
Q1
$5.36M Sell
28,200
-22,000
-44% -$4.2M 0.53% 38
2018
Q4
$9.77M Buy
50,200
+7,369
+17% +$1.44M 1.61% 15
2018
Q3
$8.88M Buy
+42,831
New +$8.44M 1.05% 24

Other funds holding AMGN

Tibra Equities Europe's AMGN Position: Q4 2019 in Review

Tibra Equities Europe sold out of Amgen (AMGN) in Q4 2019, closing a stake of 19,700 shares — an estimated $3.81M sold.

Tibra Equities Europe first reported a position in AMGN in Q3 2018 and held it in 5 quarters. The position peaked at $9.77M in Q4 2018. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • Tibra Equities Europe reported no remaining Amgen position as of Q4 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 19,700 Amgen shares in Q4 2019, an estimated $3.81M.
  • Tibra Equities Europe first reported a position in Amgen in Q3 2018 and held it in 5 quarters.
  • Tibra Equities Europe's Amgen position peaked at $9.77M in Q4 2018.
  • 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.